Voltage-gated calcium channel alpha-2-delta-1 subunit (Alpha-2-delta-1 (often symbolized as α2δ1))

The voltage-gated calcium channel alpha-2-delta-1 subunit is an *extracellular auxiliary protein* critical for the function of high-voltage activated calcium channels. The subunit modulates channel kinetic and voltage sensitivity and enhances the trafficking of channel complexes to the plasma membrane, increasing calcium current density[7][5][1]. It is encoded by the CACNA2D1 gene and forms part of a multi-protein complex with alpha-1 (pore-forming), beta, and sometimes gamma subunits. *Alpha-2-delta-1* is the molecular target of gabapentinoid drugs (gabapentin, pregabalin, mirogabalin), which are approved treatments for neuropathic pain. This subunit also acts as a marker for some tumor-initiating cells in cancer and participates in synaptic organization, cell death signaling, and neuroprotection[2][4][5][3]. The role of alpha-2-delta-1 in channel trafficking and neurotransmission makes it a significant target for both pain management and research in neurological and neoplastic diseases[2][4][6][7].

Other names

Voltage-dependent calcium channel subunit alpha-2/delta-1Alpha-2/delta-1CACNA2D1Cavα2δ1

Gabapentinoid drugs bind directly to the alpha-2-delta-1 subunit, inhibiting its function, which reduces the trafficking and activity of voltage-gated calcium channels, ultimately suppressing neurotransmitter release and dampening synaptic excitability.